中国医药
(600056)
| 流通市值：137.72亿 | | | 总市值：137.77亿 |
| 流通股本：14.95亿 | | | 总股本：14.96亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,409,805,111.08 | 4,088,893,984.89 | 2,368,947,896.5 | 2,999,554,381.83 |
| 交易性金融资产 | 122,283,434.58 | 122,283,434.58 | 128,730,210.41 | 128,730,210.41 |
| 应收票据及应收账款 | 15,862,965,352.32 | 14,345,809,500.02 | 15,835,513,640.53 | 14,964,260,471.64 |
| 其中：应收票据 | 201,189,134.26 | 163,190,145.75 | 328,800,252.99 | 203,592,190.41 |
| 应收账款 | 15,661,776,218.06 | 14,182,619,354.27 | 15,506,713,387.54 | 14,760,668,281.23 |
| 应收款项融资 | 622,108,555.83 | 564,180,101.58 | 353,176,058.17 | 348,003,755.81 |
| 预付款项 | 1,053,612,340.47 | 789,458,472.3 | 1,007,211,521.41 | 1,120,048,675.02 |
| 其他应收款合计 | 1,714,681,738.48 | 1,818,350,443.63 | 1,861,667,890.3 | 1,697,815,178.16 |
| 存货 | 6,196,065,259.14 | 6,072,507,057.85 | 6,238,388,125 | 6,248,545,517.99 |
| 合同资产 | 41,600,245.42 | 42,763,856.89 | 16,281,577.15 | 27,856,201.55 |
| 一年内到期的非流动资产 | 3,463,667.17 | 3,192,911.18 | - | - |
| 其他流动资产 | 253,283,856.19 | 231,621,759.84 | 241,020,751.06 | 287,456,574.65 |
| 流动资产合计 | 28,279,869,560.68 | 28,079,061,522.76 | 28,050,937,670.53 | 27,822,270,967.06 |
| 非流动资产: | | | | |
| 长期应收款 | 8,201,460.31 | 8,116,708.7 | 11,218,240.03 | 11,120,646.38 |
| 长期股权投资 | 2,695,845,129.5 | 2,687,623,629.5 | 2,734,648,148.36 | 2,722,004,968.26 |
| 其他权益工具投资 | 42,878,842.51 | 46,998,005.22 | 47,168,046.76 | 47,168,046.76 |
| 投资性房地产 | 89,681,416.99 | 88,608,056.98 | 89,674,591.51 | 90,782,571.34 |
| 固定资产 | 2,223,554,559.51 | 2,279,728,619.4 | 2,233,545,298.48 | 2,272,556,825.81 |
| 在建工程 | 285,767,384.47 | 280,225,098.23 | 292,846,057.48 | 208,363,658.86 |
| 使用权资产 | 334,017,739.61 | 195,703,619.36 | 227,331,573.55 | 259,848,011.23 |
| 无形资产 | 782,878,735.38 | 768,586,431.46 | 711,591,566.07 | 672,045,668.76 |
| 开发支出 | 451,217,827.75 | 473,533,430.92 | 479,041,963.23 | 495,495,305.48 |
| 商誉 | 878,276,253.25 | 878,276,253.25 | 996,062,765.04 | 996,062,765.04 |
| 长期待摊费用 | 145,295,673.41 | 145,113,887.44 | 150,133,219.39 | 143,422,322.27 |
| 递延所得税资产 | 683,546,388.17 | 681,483,203.27 | 715,563,027.48 | 707,518,233.54 |
| 其他非流动资产 | 576,226,560.75 | 257,911,341.28 | 247,823,158.4 | 263,284,547.6 |
| 非流动资产合计 | 9,197,387,971.61 | 8,791,908,285.01 | 8,936,647,655.78 | 8,889,673,571.33 |
| 资产总计 | 37,477,257,532.29 | 36,870,969,807.77 | 36,987,585,326.31 | 36,711,944,538.39 |
| 流动负债: | | | | |
| 短期借款 | 4,343,733,256.98 | 3,979,252,760.88 | 4,444,016,834.96 | 4,129,091,717.07 |
| 应付票据及应付账款 | 10,655,098,955.72 | 10,338,050,451.2 | 9,700,720,766.34 | 9,599,411,225.99 |
| 其中：应付票据 | 2,166,783,220.85 | 2,145,698,955.95 | 1,533,524,699.21 | 1,822,637,750.45 |
| 应付账款 | 8,488,315,734.87 | 8,192,351,495.25 | 8,167,196,067.13 | 7,776,773,475.54 |
| 预收款项 | 1,450,382.26 | 1,085,005.45 | 2,220,611.06 | 2,789,275.63 |
| 合同负债 | 1,095,618,312.14 | 1,166,723,572.17 | 1,137,735,758.6 | 1,016,590,847.39 |
| 应付职工薪酬 | 171,289,543.96 | 283,549,956.02 | 215,942,140.08 | 185,955,647.85 |
| 应交税费 | 217,093,400.1 | 257,707,206.08 | 207,074,973.18 | 199,914,071.07 |
| 其他应付款合计 | 2,046,077,468.46 | 1,997,454,170.58 | 2,884,092,475.45 | 3,062,119,549.7 |
| 应付股利 | 2,531,145.59 | 2,531,145.59 | 15,254,533.95 | 130,562,628.01 |
| 一年内到期的非流动负债 | 149,352,950.57 | 462,247,827 | 852,526,565.71 | 1,267,652,199.87 |
| 其他流动负债 | 1,194,214,944.15 | 1,239,443,014.32 | 203,848,888.72 | 189,965,873.55 |
| 流动负债合计 | 19,873,929,214.34 | 19,725,513,963.7 | 19,648,179,014.1 | 19,653,490,408.12 |
| 非流动负债: | | | | |
| 长期借款 | 770,550,000 | 670,750,000 | 867,500,000 | 719,800,000 |
| 租赁负债 | 272,974,653.5 | 147,301,144.54 | 183,305,474 | 201,883,162.05 |
| 长期应付款 | 1,876,074,101.07 | 1,881,040,951.47 | 1,873,173,051.47 | 1,883,675,795.65 |
| 长期应付职工薪酬 | 14,661,947.73 | 15,181,022.67 | 15,108,087.8 | 15,510,796.45 |
| 预计负债 | 1,686,000.26 | 1,705,750.26 | - | - |
| 递延收益 | 63,202,250.18 | 62,709,554.07 | 65,111,229.72 | 65,385,547 |
| 递延所得税负债 | 3,398,939.18 | 3,168,749.8 | 44,303,269.71 | 44,233,386.58 |
| 非流动负债合计 | 3,002,547,891.92 | 2,781,857,172.81 | 3,048,501,112.7 | 2,930,488,687.73 |
| 负债合计 | 22,876,477,106.26 | 22,507,371,136.51 | 22,696,680,126.8 | 22,583,979,095.85 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 |
| 资本公积 | 1,601,099,923.38 | 1,601,099,923.38 | 1,799,105,055.7 | 1,799,105,055.7 |
| 其他综合收益 | -8,944,829.07 | -7,418,937.88 | 1,706,154.59 | 3,720,973.91 |
| 盈余公积 | 666,225,375.09 | 666,225,375.09 | 630,553,833.6 | 630,553,833.6 |
| 未分配利润 | 8,263,744,193.01 | 8,080,162,611.12 | 7,925,711,711.58 | 7,794,316,201.7 |
| 归属于母公司股东权益合计 | 12,018,004,410.41 | 11,835,948,719.71 | 11,852,956,503.47 | 11,723,575,812.91 |
| 少数股东权益 | 2,582,776,015.62 | 2,527,649,951.55 | 2,437,948,696.04 | 2,404,389,629.63 |
| 股东权益合计 | 14,600,780,426.03 | 14,363,598,671.26 | 14,290,905,199.51 | 14,127,965,442.54 |
| 负债和股东权益合计 | 37,477,257,532.29 | 36,870,969,807.77 | 36,987,585,326.31 | 36,711,944,538.39 |
| 公告日期 | 2026-04-29 | 2026-04-25 | 2025-10-28 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |